pirenzepine has been researched along with Gastritis in 14 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
Excerpt | Relevance | Reference |
---|---|---|
"The extent of acid secreting areas and the distribution of intestinal metaplasia in patients with erosive gastritis, and the healing effects of pirenzepine were examined." | 9.06 | Relationship of erosive gastritis to the acid secreting area and intestinal metaplasia, and the healing effect of pirenzepine. ( Iishi, H; Okuda, S; Tatsuta, M, 1987) |
" Because it has been suggested that the lower relapse rate for duodenal ulcer following colloidal bismuth subcitrate (CBS) is due to suppression of C pylori we investigated different formulations and dosing of CBS for their efficacy in clearing C pylori." | 6.66 | Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol). ( Ali, MR; Brown, P; Lane, M; Morris, A; Palmer, R, 1988) |
"Antral biopsy specimens from 89 consecutive patients with nonulcer dyspepsia and erosive prepyloric changes included in a prospective, randomized, double-blind 4-wk study of the effect of an aluminum-magnesium antacid (120 mmol/day) or pirenzepine (50 mg b." | 5.06 | Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes. ( Alexander, B; Berstad, A; Hirschowitz, BI; Holland, S; Serck-Hanssen, A; Weberg, R, 1988) |
"Pirenzepine (PRZ, 75 mg/day for 10 days followed by 50 mg/day for 20 days) was compared with placebo (PL) in the treatment of endoscopically confirmed active gastroduodenitis or duodenal ulcer and with carbenoxolone (CB, 300 mg/day followed by 200 mg/day) in the treatment of gastric ulcer in a 30-day double-blind clinical trial." | 5.04 | Pirenzepine in the treatment of benign gastroduodenal diseases. A double-blind controlled clinical trial. ( Cifani, G; D'Anchino, M; Di Tommaso, B; Gasbarrini, G; Giorgi-Conciato, M; Pesa, O; Sollecito, A, 1979) |
" Because it has been suggested that the lower relapse rate for duodenal ulcer following colloidal bismuth subcitrate (CBS) is due to suppression of C pylori we investigated different formulations and dosing of CBS for their efficacy in clearing C pylori." | 2.66 | Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol). ( Ali, MR; Brown, P; Lane, M; Morris, A; Palmer, R, 1988) |
"Chronic alcoholic gastritis is a very important social problem in the Health District of Arezzo, which covers an area where wine is an integral part of the diet." | 2.66 | [Alcoholic gastropathy. Notes on its epidemiology and the therapeutic experience using pirenzepine]. ( Agnolucci, A; Angioli, D; Caneschi, F; Cucinelli, ML; Magnolfi, F; Pichi, V; Rossi, G; Valentini, P, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (92.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Serebrova, SIu | 1 |
Lagarde, SP | 1 |
Spiro, HM | 1 |
Giorgi-Conciato, M | 2 |
Daniotti, S | 1 |
Ferrari, PA | 1 |
Gaetani, M | 1 |
Petrin, G | 1 |
Sala, P | 1 |
Valentini, P | 3 |
Giaccari, S | 1 |
Tronci, S | 1 |
De Maria, E | 1 |
Chirletti, P | 1 |
Colobraro, P | 1 |
Romano, R | 1 |
Barzi, A | 1 |
Mangialardi, N | 1 |
Bertoldi, I | 1 |
Cirenei, A | 1 |
Plottin, F | 1 |
Capony, P | 1 |
Meullenet, J | 1 |
Fournet, J | 1 |
Gasbarrini, G | 1 |
D'Anchino, M | 1 |
Di Tommaso, B | 1 |
Pesa, O | 1 |
Sollecito, A | 1 |
Cifani, G | 1 |
Morris, A | 1 |
Brown, P | 1 |
Ali, MR | 1 |
Lane, M | 1 |
Palmer, R | 1 |
Kishimoto, S | 1 |
Kobuke, K | 1 |
Kobayashi, H | 1 |
Kato, R | 1 |
Kajiyama, G | 1 |
Miyoshi, A | 1 |
Weberg, R | 2 |
Berstad, A | 2 |
Alexander, B | 1 |
Serck-Hanssen, A | 1 |
Holland, S | 1 |
Hirschowitz, BI | 1 |
Tatsuta, M | 1 |
Iishi, H | 1 |
Okuda, S | 1 |
Toft, E | 1 |
Kristensen, OK | 1 |
Magnolfi, F | 1 |
Agnolucci, A | 1 |
Rossi, G | 1 |
Caneschi, F | 1 |
Pichi, V | 1 |
Cucinelli, ML | 1 |
Angioli, D | 1 |
1 review available for pirenzepine and Gastritis
Article | Year |
---|---|
Non-ulcer dyspepsia.
Topics: Antacids; Benzodiazepinones; Diet; Duodenitis; Dyspepsia; Gastric Acid; Gastritis; Gastrointestinal | 1984 |
7 trials available for pirenzepine and Gastritis
Article | Year |
---|---|
Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
Topics: Adult; Benzodiazepinones; Carbenoxolone; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Duode | 1982 |
Pirenzepine in the treatment of benign gastroduodenal diseases. A double-blind controlled clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzodiazepinones; Clinical Trials as Topic; Double-Blin | 1979 |
Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Topics: Administration, Oral; Adult; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Clinical Tria | 1988 |
Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial.
Topics: Adult; Antacids; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Female; Gastric Mucosa; G | 1988 |
Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Campylobacter; Clinical Trials as Topic; Double-Blind Meth | 1988 |
Relationship of erosive gastritis to the acid secreting area and intestinal metaplasia, and the healing effect of pirenzepine.
Topics: Adult; Aged; Biopsy; Clinical Trials as Topic; Double-Blind Method; Female; Gastric Mucosa; Gastriti | 1987 |
[Alcoholic gastropathy. Notes on its epidemiology and the therapeutic experience using pirenzepine].
Topics: Adult; Aged; Alcoholism; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Gas | 1986 |
6 other studies available for pirenzepine and Gastritis
Article | Year |
---|---|
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Aci | 2007 |
[Pirenzepin in the treatment of toxic gastroduodenitis in chronic alcoholics].
Topics: Alcoholism; Benzodiazepinones; Drug Evaluation; Duodenitis; Gastritis; Humans; Pirenzepine | 1984 |
[Pirenzepine parenterally administered in high doses in the treatment of upper digestive hemorrhage].
Topics: Adult; Aged; Benzodiazepinones; Duodenitis; Female; Gastritis; Gastrointestinal Hemorrhage; Humans; | 1984 |
[Treatment of Ménétrier's disease with pirenzepine].
Topics: Aged; Benzodiazepinones; Gastritis; Gastritis, Hypertrophic; Humans; Male; Pirenzepine | 1983 |
Preventive effect of pirenzepine on atrophic erosive gastritis in rats.
Topics: Animals; Gastritis; Gastritis, Atrophic; Male; Pirenzepine; Rats; Rats, Inbred Strains; Taurocholic | 1988 |
[Menetrier's disease treated with pirenzepine].
Topics: Adult; Female; Gastritis; Gastritis, Atrophic; Humans; Male; Pirenzepine | 1988 |